GSA CAPITAL PARTNERS LLP - ISIS PHARMACEUTICALS INC ownership

ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 347 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$2,832,000
-61.4%
70,059
-45.0%
0.14%
-50.7%
Q2 2015$7,333,000
+168.4%
127,412
+197.0%
0.28%
+158.7%
Q1 2015$2,732,000
+832.4%
42,901
+803.0%
0.11%
+445.0%
Q4 2014$293,000
-68.3%
4,751
-82.3%
0.02%
-52.4%
Q2 2014$924,000
-72.6%
26,814
-65.6%
0.04%
-82.5%
Q1 2014$3,370,000
+383.5%
77,984
+345.5%
0.24%
+336.4%
Q4 2013$697,000
+4.0%
17,506
-2.0%
0.06%
+3.8%
Q3 2013$670,00017,8580.05%
Other shareholders

There were no reported owners of ISIS PHARMACEUTICALS INC in Q1 2015.

NameSharesValueWeighting ↓
View complete list of ISIS PHARMACEUTICALS INC shareholders